About this document "ctDNA MRD assay (experimental)": How much does ctDNA MRD assay (experimental) typically cost
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
According to the document, the ctDNA MRD assay (experimental) costs approximately $600.
Important additional context about this test:
- The document indicates this is not currently covered by insurance
- It is considered an experimental test
- The turnaround time is 10-14 days
According to the NCCN Guidelines for Follicular Lymphoma and the American Society of Clinical Oncology (ASCO) guidelines, while circulating tumor DNA (ctDNA) testing shows promise for monitoring minimal residual disease (MRD), it is still considered investigational. The National Cancer Institute (NCI) notes that ctDNA testing for lymphoma monitoring is an active area of research but is not yet standard of care.
I want to emphasize that since this is listed as an experimental test, patients should:
- Discuss with their healthcare team whether this testing is appropriate for their specific situation
- Confirm current pricing with the testing facility as costs may vary
- Understand that since it's not covered by insurance, this would likely be an out-of-pocket expense
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with clinical trials for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ